middle.news
BCAL Diagnostics Unveils Blood Test Targeting Local Breast Cancer Recurrence
9:52am on Thursday 18th of June, 2026 AEST
•
Healthcare
Read Story
BCAL Diagnostics Unveils Blood Test Targeting Local Breast Cancer Recurrence
9:52am on Thursday 18th of June, 2026 AEST
Key Points
BREASTEST Monitor detects local breast cancer recurrence with 91% sensitivity
Test offers a non-invasive alternative to costly imaging methods
Addresses surveillance needs for millions of breast cancer survivors
Further clinical validation required before commercial launch
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bcal Diagnostics (ASX:BDX)
OPEN ARTICLE